Rib-X Pharmaceuticals Inc New Haven, CT - 06511

Rib-X Pharmaceuticals Inc is categorized under Pharmaceutical Research Laboratories in New Haven, CT .

Rib-X Pharmaceuticals Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Pharmaceutical Research Laboratories business, which does work in the B2B market, and is classified as a Pharmaceutical Research Laboratories, under code number 5417112 by the NAICS.

If you are seeking more information, feel free to contact Mary Szela, Chief Executive Officer at the company’s single location by writing to 300 George St # 301, New Haven, Connecticut CT 06511 or by phoning (203) 624-5606. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Rib-X Pharmaceuticals Inc
Contact Person: Mary Szela, Chief Executive Officer
Address: 300 George St # 301, New Haven, Connecticut 06511
Phone Number: (203) 624-5606
Website Address: rib-x.com
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Pharmaceutical Research Laboratories
SIC Code: 8731
NAICS Code: 5417112
Share This Business:

Rib-X Pharmaceuticals Inc was started in 0 to provide professional Pharmaceutical Research Laboratories under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Mary Szela, Chief Executive Officer for inquiries that concern Rib-X Pharmaceuticals Inc by calling the company number (203) 624-5606, as your correspondence is most welcome. Additionally, the physical location of the single location of Rib-X Pharmaceuticals Inc can be found at the coordinates 41.305315,-72.931123 as well as the street address 300 George St # 301 in New Haven, Connecticut 06511.

For its online presence, you may visit Rib-X Pharmaceuticals Inc’s website at rib-x.com and engage with its social media outlets through on Twitter and on Facebook.